NCT03346603View on ClinicalTrials.gov

Prevalence of Antimicrobial-resistant Pathogens in Patients Admitted for UTIs

CompletedOBSERVATIONAL
Enrollment

801

Participants

Timeline

Start Date

February 8, 2018

Primary Completion Date

February 28, 2019

Study Completion Date

December 31, 2020

Conditions
Urinary Tract InfectionsUrosepsis
Interventions
OTHER

urine culture and susceptibility testing

All patients will have a urine culture and susceptibility test ordered per standard care. Results of tests will identify which patients have antimicrobial-resistant organisms.

Trial Locations (1)

93311

Olive View-UCLA Medical Center, Sylmar

Sponsors

Collaborators (1)

IHMA laboratories
All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

IHMA laboratories

UNKNOWN

lead

Olive View-UCLA Education & Research Institute

OTHER

NCT03346603 - Prevalence of Antimicrobial-resistant Pathogens in Patients Admitted for UTIs | Biotech Hunter | Biotech Hunter